Title |
Intravenous enalaprilat for treatment of acute hypertensive heart failure in the emergency department
|
---|---|
Published in |
International Journal of Emergency Medicine, December 2016
|
DOI | 10.1186/s12245-016-0125-4 |
Pubmed ID | |
Authors |
Syed Imran Ayaz, Craig M. Sharkey, Gregory M. Kwiatkowski, Suprat Saely Wilson, Reba S. John, Rosa Tolomello, Arushi Mahajan, Scott Millis, Phillip D. Levy |
Abstract |
Afterload reduction with bolus enalaprilat is used by some for management of acute hypertensive heart failure (HF) but existing data on the safety and effectiveness of this practice are limited. The purpose of this study was to evaluate the clinical effects of bolus enalaprilat when administered to patients with acute hypertensive heart failure. We performed an IRB-approved retrospective cohort study of patients who presented to the emergency department of a large urban academic hospital. Patients were identified by pharmacy record and included if they received enalaprilat intravenous (IV) bolus in the setting of acute hypertensive HF. A total of 103 patients were included. Patients were hypertensive on presentation (systolic blood pressure [SBP] = 195.2 [SD ± 32.3] mmHg) with significantly elevated mean NT-proBNP levels (3797.8 [SD ± 6523.2] pg/ml). The mean dose of enalaprilat was 1.3 [SD ± 0.7] mg, with most patients (76.7%) receiving a single 1.25 mg bolus. By 3 h post-enalaprilat, SBP had decreased substantially (-30.5 mmHg) with only 2 patients (1.9%) developing hypotension. Renal function was unaffected, with no significant change in serum creatinine by 72 h. In the 30 days post-admission, patients spent an average of 23 [SD ± 7.5] days alive and out of hospital. In this retrospective cohort of acute hypertensive HF patients, bolus IV enalaprilat resulted in a substantial reduction in systolic BP without adverse effect. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 60% |
India | 1 | 20% |
Unknown | 1 | 20% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 31 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 4 | 13% |
Other | 3 | 10% |
Student > Doctoral Student | 2 | 6% |
Professor | 2 | 6% |
Student > Bachelor | 2 | 6% |
Other | 4 | 13% |
Unknown | 14 | 45% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 13 | 42% |
Biochemistry, Genetics and Molecular Biology | 1 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Agricultural and Biological Sciences | 1 | 3% |
Nursing and Health Professions | 1 | 3% |
Other | 0 | 0% |
Unknown | 14 | 45% |